A detailed history of Palisade Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Palisade Capital Management LLC holds 320 shares of LLY stock, worth $249,280. This represents 0.01% of its overall portfolio holdings.

Number of Shares
320
Holding current value
$249,280
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $247,084 - $307,206
320 New
320 $283,000
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $59,845 - $74,373
-255 Reduced 25.5%
745 $213,000
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $224,850 - $279,040
1,000 New
1,000 $276,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.